Evidence has shown that neurofilament light chain, matrix metalloproteinase‐9, interleukin‐17, nitric oxide, and leukocyte differential count are reliable indicators of axonal damage, demyelination, inflammation, oxidative stress, and infiltration of immune cells in MS patients, respectively.3, 4. The gene discussed is NEFL; the disease is myeloid sarcoma.